Airway Control Flashcards
Understand autonomic innervation pharmacology of bronchial smooth muscle
Sympathetic:
B-adrenoceptors (B2) cause bronchodilation via decreased histamine release and increased mucociliary clearance
Parasympathetic:
M3 receptors maintain smooth muscle tone
Inhibitory/excitatory NANC innervation (neurotransmitters)
Describe the main features underlying pathophysiology of asthma including that responsible for early and late phase response
Immediate phase - mast cell fixed IgE –> histamine release –> bronchospasm
Late phase - leucocytes –> epithelial damage, exacerbated bronchospasm and congestion
Thickening of BM, oedema, mucus
Bronchial hyperresponsiveness - an exaggerated bronchoconstrictor response to direct pharmacological stimuli (histamine) or indirect stimuli (e.g. exercise)
Describe the action of short and long acting B2 agonists, ADRs and when they are used
MOA - Gs –> increased cAMP –> protein kinase A –> decreased intracellular calcium –> hyperpolarisation of muscle cells –> bronchodilation
Short acting e.g. salbutamol, terbutaline, formoterol
Long acting e.g. salmeterol, formoterol
ADRs - skeletal muscle tremor, tachycardia, dysrhytmia
Describe the action of methylxanthines, ADRs and when they are used
E.g. theophylline, aminophylline
MOA - adenosine receptor antagonist –> bronchodilation
ADRs - psychomotor retardation, tachycardia
Describe the action of muscarinic receptor antagonists, ADRs and when they are used
E.g. ipratroprium, tiotropium
MOA - bind to M3 receptor –> blocks constricting effects of ACh, inhibits mucus secretion
ADRs - dizziness, dry mouth
*Not first line in asthma, used in COPD
Understand the broad mechanism of anti-inflammatory action of the corticosteroids and ADRs
E.g. prednisolone
MOA - suppress gene transcription in pro inflammatory cells, decrease eosinophil lung infiltration, increase B2 receptors, anti-inflammatory IL, induce apoptosis of inflammatory cells, decreased mast cells
ADRs - croaky voice, sore throat, oral thrush
Outline the general steps in management of asthma
Stepwise Approach to Dosing in BNF: minimises effect of long term high dose glucocorticoids
Step 1 - SABA
Step 2 - + ICS
Step 3 - + LABA
Step 4 - + LRA/anti-muscarinic/methylxanthine
Step 5 - +oral steroid/IgE
Describe the steps in management of severe acute asthma
Supplementary oxygen to maintain SpO2 level of 94-98% B2 agonist bronchodilators Ipatropium bromide Corticosteroids IV magnesium sulphate?